PROEHL GERALD T has filed 19 insider transactions across 2 companies since January 2024.
Most recent transaction: a grant/award of 3000 shares of TENAX THERAPEUTICS, INC. ($TENX) on January 09, 2026.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 9, 2026 | TENAX THERAPEUTICS, INC. | $TENX | PROEHL GERALD T | Director | A | Stock Option (right to buy) | 3000 | $0.00 | 210,010.0000 | 39,741,404 | 1.45% | 0.01% |
| Jan. 2, 2026 | Dermata Therapeutics, Inc. | $DRMA | PROEHL GERALD T | President, CEO and Chairman | A | Stock Option (right to buy) | 37500 | $0.00 | 37,500.0000 | 1,026,457 | 9999.99% | 3.65% |
| Dec. 23, 2025 | Dermata Therapeutics, Inc. | $DRMA | PROEHL GERALD T | PRESIDENT, CHAIRMAN, CEO | A | Common Stock | 490196 | $0.00 | 692,647.0000 | 1,026,457 | 242.13% | 47.76% |
| Dec. 23, 2025 | Dermata Therapeutics, Inc. | $DRMA | PROEHL GERALD T | PRESIDENT, CHAIRMAN, CEO | A | Common Stock | 122549 | $0.00 | 692,647.0000 | 1,026,457 | 21.50% | 11.94% |
| Dec. 23, 2025 | Dermata Therapeutics, Inc. | $DRMA | PROEHL GERALD T | PRESIDENT, CHAIRMAN, CEO | A | Series C Warrant (Right to Buy) | 490196 | $0.00 | 613,045.0000 | 1,026,457 | 399.02% | 47.76% |
| Dec. 23, 2025 | Dermata Therapeutics, Inc. | $DRMA | PROEHL GERALD T | PRESIDENT, CHAIRMAN, CEO | A | Series D Warrant (Right to Buy) | 490196 | $0.00 | 613,045.0000 | 1,026,457 | 399.02% | 47.76% |
| Dec. 23, 2025 | Dermata Therapeutics, Inc. | $DRMA | PROEHL GERALD T | PRESIDENT, CHAIRMAN, CEO | A | Series C Warrant (Right to Buy) | 122549 | $0.00 | 613,045.0000 | 1,026,457 | 24.98% | 11.94% |
| Dec. 23, 2025 | Dermata Therapeutics, Inc. | $DRMA | PROEHL GERALD T | PRESIDENT, CHAIRMAN, CEO | A | Series D Warrant (Right to Buy) | 122549 | $0.00 | 613,045.0000 | 1,026,457 | 24.98% | 11.94% |
| Dec. 23, 2025 | Dermata Therapeutics, Inc. | $DRMA | PROEHL GERALD T | PRESIDENT, CHAIRMAN, CEO | D | Warrant (Right to Buy) | 78740 | $0.00 | 0.0000 | 1,026,457 | 0.00% | 7.67% |
| Dec. 23, 2025 | Dermata Therapeutics, Inc. | $DRMA | PROEHL GERALD T | PRESIDENT, CHAIRMAN, CEO | A | Warrant (Right to Buy) | 78740 | $0.00 | 78,740.0000 | 1,026,457 | 9999.99% | 7.67% |
| July 1, 2025 | TENAX THERAPEUTICS, INC. | $TENX | PROEHL GERALD T | Not found | A | Stock Option (right to buy) | 80000 | $0.00 | 180,010.0000 | 15,271,705 | 79.99% | 0.52% |
| Jan. 21, 2025 | Dermata Therapeutics, Inc. | $DRMA | PROEHL GERALD T | President, CEO and Chairman | A | Warrant (Right to Buy) | 787402 | $0.00 | 787,402.0000 | 0 | 9999.99% | 0.00% |
| Jan. 21, 2025 | Dermata Therapeutics, Inc. | $DRMA | PROEHL GERALD T | President, CEO and Chairman | A | Common Stock | 787402 | $0.00 | 800,610.0000 | 0 | 5961.55% | 0.00% |
| Jan. 13, 2025 | Dermata Therapeutics, Inc. | $DRMA | PROEHL GERALD T | President, CEO and Chairman | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 10, 2024 | TENAX THERAPEUTICS, INC. | $TENX | PROEHL GERALD T | Not found | A | Stock Option (right to buy) | 100000 | $0.00 | 100,010.0000 | 21,161,143 | 9999.99% | 0.47% |
| Aug. 8, 2024 | TENAX THERAPEUTICS, INC. | $TENX | PROEHL GERALD T | Not found | P | Common Stock | 1666 | $0.00 | 1,667.0000 | 248,447 | 9999.99% | 0.67% |
| Aug. 8, 2024 | TENAX THERAPEUTICS, INC. | $TENX | PROEHL GERALD T | Not found | P | Pre-Funded Warrant | 31654 | $0.00 | 31,654.0000 | 248,447 | 9999.99% | 12.74% |
| Aug. 8, 2024 | TENAX THERAPEUTICS, INC. | $TENX | PROEHL GERALD T | Not found | P | Warrant | 16660 | $0.00 | 16,660.0000 | 248,447 | 9999.99% | 6.71% |
| Jan. 4, 2024 | Dermata Therapeutics, Inc. | $DRMA | PROEHL GERALD T | President, CEO and Chairman | A | Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |